机器人经腹腔入路腹膜后肿瘤切除术的临床应用  

Clinical application of robot-assisted retroperitoneal tumor resection via transabdominal approach

作　　者：林荣贵[1] 黄鹤光[1] 陈燕昌[1] 陆逢春[1] 林贤超[1] 杨媛媛[1] 王丛菲[1] 方海宗[1] LIN Ronggui;HUANG Heguang;CHEN Yanchang;LU Fengchun;LIN Xianchao;YANG Yuanyuan;WANG Congfei;FANG Haizong(Department of General Surgery,Fujian Medical University Union Hospital,Fuzhou 350001,China)

机构地区：[1]福建医科大学附属协和医院基本外科,福建福州350001

出　　处：《机器人外科学杂志（中英文）》2020年第3期180-185,共6页Chinese Journal of Robotic Surgery

基　　金：福建省微创医学中心项目(闽卫医政函[2017]171);福建省医学临床重点专科建设项目(闽财指[2012]649)。

摘　　要：目的:探讨机器人经腹腔入路腹膜后肿瘤切除术的临床应用。方法:回顾性分析2016年11月~2020年3月福建医科大学附属协和医院施行的机器人经腹腔入路腹膜后肿瘤切除术的14例腹膜后肿瘤患者的临床资料,总结手术经验和技巧。结果:所有病例均顺利完成机器人手术,无中转,无围手术期死亡病例。肿瘤最大径3~14cm,平均6cm;手术时间60~400min,平均135min;术中出血量10~200ml,平均20ml;术后恢复进食时间1~3d,平均2d;术后住院时间3~11d,平均6d。无严重术中、术后并发症发生。结论:机器人经腹腔入路腹膜后肿瘤切除术对于选择适当的良性腹膜后肿瘤是安全、有效的,且术后恢复快,并发症少。Objective:To evaluate clinical application of robot-assisted retroperitoneal tumor resection via transabdominal approach.Methods:14 patients with retroperitoneal tumor in Fujian Medical University Union Hospital from November 2016 to March 2020 were enrolled in this retrospective study.Clinical data of the patients were collected to summarize operative skills and experiences.Results:All the operations were successfully completed without conversion into open surgery.No death occurred in perioperative period.Average diameter of tumor was 6(3-14)cm,average operative time was 135(60-400)min and the average intraoperative blood loss was 20(10-200)ml.Average postoperative eating time was 2(1-3)d and average postoperative hospital stay time was 6(3-11)d.No severe intraoperative or postoperative complications occurred.Conclusion:Robot-assisted retroperitoneal tumor resection via transabdominal approach is a feasible and safe way to treat well-selected benign retroperitoneal tumors with fast recovery and few complications.

关 键 词：机器人 腹膜后肿瘤 微创 

分 类 号：R656[医药卫生—外科学] R739.9[医药卫生—临床医学]